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Non-equimolar discrete compounds in binary
chiral systems of organic substances†
Elena N. Kotelnikova, a Anton I. Isakova and Heike Lorenz*b
Since knowledge on the occurrence of non-equimolar discrete compounds in binary systems containing
chiral molecules is very limited, this study reviews and systematizes the current state of investigating such
systems and summarizes the results on two example systems studied in detail by the authors. In particular,
the identification and verification of the non-equimolar discrete compounds compared to other discrete
solid phases occurring in the two systems are discussed by presenting the results of related SCXRD, PXRD,
TRPXRD, DSC, IR, and HSM studies. The (S)-malic acid–(R)-malic acid system has been found to contain
non-equimolar 1 : 3 and 3 : 1 stable (S3R and SR3) and metastable (3S1R and 1S3R) discrete compounds,
along with the equimolar compounds RSI and RSII (known monoclinic modifications) and the recently dis-
covered RSIII modification. Polymorphic transformations of the discrete phases are debated, and the crystal
structure of the stable compound S3R is identified (S. G. P1). The L-valine–L-isoleucine system has been stated
to contain a non-equimolar 2 : 1 discrete compound, V2I, that could independently be proven by the ternary
solubility diagram in water and its crystal structure solved (S. G. C2). The results obtained are discussed in
conjunction with the findings reported in the literature. In order to systematize the variety of terms used
for the description of discrete phases in binary chiral systems of organic substances, a systematization of
equimolar and non-equimolar compounds based on chemical and crystallographic characteristics is
proposed.
1. Introduction
When studying the limits of solid solutions and the poly-
morph diversity of organic compounds, several geometric
and chemical factors are taken into account, such as dimen-
sions, shape, and symmetry of a molecule, as well as the type
of intermolecular bonding.1–3 In the last decades, further
geometrical (stereochemical) factors – the molecule chirality
and its configuration4 – have been found to be essential for
the analysis of molecular packing in crystal structures of
enantiomeric compounds.5,6 An avalanche-like growing inter-
est in a rather abundant class of organic substances that con-
tain chiral molecules is prompted by their numerous applica-
tions in the pharmaceutical industry, medicine,
biochemistry7–11 and even in geology,12–16 where they are
used, for example, for sediment rock dating; the last method
is based on interrelations between levorotatory and dextroro-
tatory enantiomers in fossilized organic matter.13,16 Indus-
trial use and treatment of biochemically active chiral com-
pounds requires development and improvement of synthesis
techniques and also of methods for chiral resolution and
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purification. This requires, in its turn, a fundamental knowl-
edge and understanding of the phase equilibria and crystal
chemistry in chiral systems.6–20
The three general types of phase diagrams known for chi-
ral systems are shown in Fig. 1 (upper part).5,21 These are dia-
grams containing a eutectic (Fig. 1a), a binary compound
(Fig. 1b), and (complete) solid solutions (Fig. 1c). The exact
type of phase diagram is determined by the nature of the
equimolar (1 : 1) mixture of enantiomers. The diagram of the
first type corresponds to a physical mixture of enantiomers,
or conglomerate, S + R; the second type to a binary com-
pound (racemic compound5), RS; and the third type to a solid
solution, S,R. Schematic representations of the equimolar
compositions that correspond to the three types mentioned
are illustrated in Fig. 1 (bottom part). The maximum of the
liquidus line of the racemic compound can lie above or below
the melting points of the enantiomers or even be equal to
them (Fig. 1b). So, the diagrams of the second type can be
further divided into three subtypes.5,6,22 Analogous subtypes
are allocated for the diagrams containing solid solutions
(Fig. 1c). According to J. Jacques et al.,5 a majority of binary
systems (∼90%) belongs to the second type, while the first
type systems are much less frequent (∼10%), with the third
type being the rarest.
A diagram of each type may be further complicated due to
polymorphism of the system components and/or equimolar
compounds. Moreover, the diagrams of the first two types
can be additionally diversified due to the formation of lim-
ited solid solutions.19 For example, in very recent work,23 C.
Brandel et al. described the complex behavior of the
diprophylline enantiomers, a system where solid solutions
form in addition to the polymorphism of both the equimolar
compound and the enantiomer.23 Possible phase diagram ar-
rangements that can result from such complications are
discussed in detail by G. Coquerel.6 However, all the dia-
grams presented there correspond to binary systems of the
same group, viz. systems consisting of enantiomers of the
same chemical compound.
In the published literature, there are sparse data on two
other groups of binary systems containing chiral molecules.
One group includes systems of diastereomers and the other
systems of enantiomers of different compounds. Examples
of our investigations of the solid phases existing in binary
systems of the three above groups are summarized in
Table 1.
The three systems of the first group24–30 contain enantio-
mers of the same compound. The system formed by the S-
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Fig. 1 Three basic types of phase diagrams characterizing binary
systems formed by S- and R-enantiomers. At the top: diagrams of the
systems containing a conglomerate (a), a racemic compound (b), and
solid solutions (c). Subtypes 1, 2, and 3 of racemic compounds have
melting points that lie above, are equal to, or lie below the melting
points of the enantiomers; subtypes 1, 2, and 3 of the solid solutions
are presented in the following order: a non-ideal solution having a
maximum, an ideal solution, and a non-ideal solution having a mini-
mum.5 At the bottom: schematic representations of molecular packing
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and R-enantiomers of the ethanolamine salt of
3-chloromandelic acid (E3ClMA) is an example of a eutectic
system with partial miscibility between the components.24,25
The system of malic acid S- and R-enantiomers belongs to the
type 2 systems showing different polymorphs of the racemic
compound and limited solid solutions.26–29 Moreover, the
system is complicated by the presence of two non-equimolar
discrete compounds, S :R = 1 : 3 and 3 : 1.29 The system of L-
and D-enantiomers of threonine is a eutectic system free from
solid solutions.30 Two shown systems of the second group
are formed by diastereomers of the same compound. D- and
L-allo-diastereomers of threonine form a eutectic system,31
where, in contrast to the L- and D-threonine system, the eutec-
tic point must be shifted from the equimolar composition. L-
and L-allo-diastereomers of threonine show full miscibility in
the solid state,32,33 and the phase diagram is asymmetric due
to different components' melting points/solubilities.32 The
third groups' system studied consists of enantiomers of dif-
ferent compounds: L-valine and L-isoleucine. This system is
characterized by the occurrence of a non-equimolar discrete
compound Val : Ile = 2 : 1 and limited solid solutions.34,35
Polymorphism of enantiomers and their equimolar com-
pounds is rather common among chiral systems.6 However,
the systems (S)-malic acid–(R)-malic acid and L-valine–L-
isoleucine show relatively rarely reported additional phase be-
haviours as limited solid solutions and, in particular, non-
equimolar discrete compounds. Both, as well as literature
data concerning these and similar systems, will be presented
in this paper. A discrete compound as used here is a solid
phase with fixed stoichiometry (equimolar or not but stoi-
chiometric) having a crystal structure different from the com-
pound components and, hence, clearly differs from solid
solutions.
The paper is structured as follows. After introducing in
section 2 the materials and experimental methods used in
our own studies, in section 3, the systems of enantiomers of
the same compound containing non-equimolar discrete
phases are reviewed and followed by a detailed discussion of
the (S)-malic acid–(R)-malic acid example. Section 4 refers to
the systems of enantiomers of different compounds containing
equimolar and non-equimolar discrete solid phases with a spe-
cial emphasis on the L-Val–L-Ile system. For both exemplary
systems, particular focus is set on discrete compounds de-
scribed recently. In section 5, a systematization of the discrete
compounds occurring in binary chiral systems of organic sub-
stances is suggested. Finally, the main results are summarized,
and conclusions are drawn.
2. Materials and methods
2.1 Materials
System 1: (S)-malic acid–(R)-malic acid. The starting reac-
tants were S- and R-enantiomers and racemates of the RSI
modification with 98% purity, which are available from
Merck Schuchardt OHG, Hohebrunn, Germany. The reactants
were used for preparing samples of quenched mixtures and
growing samples of different compositions from aqueous,
ethanol, acetone, and isopropanol solutions. The sample
preparation techniques are described in detail elsewhere.27–29
System 2: LĲ+)-valine–LĲ+)-isoleucine. The starting sub-
stances were L-valine and L-isoleucine with a 99% purity,
which are available from Alfa Aesar, Massachusetts, USA, as
well as deionized water as solvent. These reactants were used
for sample preparation by means of isothermal evaporation
and cooling techniques, as well as grinding of mixtures with
various compositions. The sample preparation techniques
are described in detail elsewhere.34,35
2.2 Experimental techniques
High-performance liquid chromatography (HPLC). An ana-
lytical HPLC system equipped with a Phenomenex Chirex
3126 column was used. System 1: The material was dissolved
in distilled water (1 wt%) and analyzed under the following
conditions: eluent − 5 mM CuSO4 at pH 3.2 (acetic acid), flow
Table 1 The solid phases formed in exemplary chiral systems of 3 groups: systems of enantiomers of the same and different compounds and diastereo-
mers of the same compound (results of our research group, except ref. 24)
Molecular components System
Number of
chiral centers Solid phase characteristics Ref.
Systems of enantiomers of the same compound
Enantiomers (S)-E3ClMA–(R)-E3ClMA 1 and 1 Eutectic mixture and limited solid solutions 24, 25
Enantiomers (S)-Malic
acid–(R)-malic acid
1 and 1 Equimolar (RS) and non-equimolar (S3R and SR3) discrete com-





2 and 2 Eutectic mixture 30
Systems of diastereomers of the same compound
Diastereomers D-Thr–L-aThr
(L-Thr–D-aThr)
2 and 2 Eutectic mixtures 31
Diastereomers L-Thr–L-aThr
(D-Thr–D-aThr)
2 and 2 Complete miscibility 32, 33
The system of enantiomers of different compounds
Enantiomers of different
compounds
L-Val–L-Ile (D-Val–D-Ile) 1 and 2 Non-equimolar discrete compound (V2I) and limited solid
solutions
34, 35
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rate − 0.5 mL min−1, injection volume − 2 μL, temperature −
25 °C, wavelength − 254 nm.29 System 2: The material was
dissolved in distilled water (up to 0.2 wt%) and analyzed
using the following conditions: eluent − 2 mM aqueous
CuSO4 solution/MeOH 85/15 (v/v), flow rate − 0.5 mL min−1,
injection volume − 5 μL, temperature − 25 °C, wavelength −
280 nm.34
Differential scanning calorimetry (DSC). System 1: For the
melting temperature measurement, a SETARAM DSC 131 unit
(France) was employed. Helium purge gas flow was 20 mL
min−1. About 10 mg of the substance were studied in closed
aluminum crucibles at a heating rate of 1 K min−1 in the
range of 30–150 °C.29 Melting temperatures were taken from
the extrapolated onset temperatures of the melting peaks.
Powder X-ray diffractometry (PXRD). System 1: Measure-
ments were performed using a Bruker D2 Phaser diffractome-
ter (Germany) applying CuKα radiation and collecting data in
2θ range of 5–45° with a step of 0.02°.29 System 2: Measure-
ments were carried out at an X'Pert Pro diffractometer
(PANalytical GmbH, Germany) using CuKα radiation and an
X'Celerator detector in a 2θ range of 3–40° with a step size of
0.017°.34 The diffraction patterns obtained for both systems
were processed using a STOE WinXPOW software package.
Temperature-resolved powder X-ray diffractometry
(TRPXRD). System 1: A STOE diffractometer (Germany) (CuKα
radiation) provided with high-temperature equipment was
used in an air atmosphere. The temperature variation was
from room temperature to the substance decomposition
point with a temperature step of 2–10 °C.27, This work
Single crystal X-ray diffractometry (SCXRD). Systems 1This
work and 2:34 A diffractometer, Agilent Technologies Super-
Nova (USA), with CuKα radiation was used at a temperature of
100 K. The structure was solved by direct methods and re-
fined by means of the SHELX program incorporated in the
OLEX2 program package.
Infrared spectroscopy (IR). System 1: A Bruker ALPHA
FT-IR-spectrometer (Germany) equipped with a Platinum-
ATR-sampling module was used for the analysis of solid
samples.This work
Hot stage microscopy (HSM). System 1: A Linkam LTS 420
hot stage (UK) combined with a Zeiss Axioskop microscope
(Germany) was applied. Samples prepared on a microscope
glass slide were continuously heated from room temperature
to the substance melting point at 2 K min−1 heating rate. The
temperature was held constant at certain temperatures to ob-
serve the changes in the sample behaviour.
3. Systems of enantiomers of the
same compound containing non-
equimolar discrete phases
3.1 Overview
A list of enantiomeric systems, which are found to contain
equimolar, as well as non-equimolar discrete compounds
(«anomalous racemates»), is presented in Table 2. Published
data on the formation of non-equimolar discrete com-
pounds in chiral systems is not always reliable, in partic-
ular, when the study is only based on melting point/
DSC analyses, and the crystal structure of the compounds
is not deciphered. A brief description of some systems is
presented below.
β-hydro-di-γ-benzoylamino-butyric acid. M. Bergmann and
M. Lissitzin51 were the first (in 1930) to introduce the concept
of so-called “anomalous racemate”. In the research,51 they
tried to separate enantiomers of β-hydro-di-γ-benzoylamino-
Table 2 Non-equimolar discrete compounds in binary systems of enantiomers
Ratio
S :R Compounds Crystal structure; methods of research Ref.
1 : 3 2,4-Dimethylglutaric acid Not determined; melt phase diagram 36, 37
1 : 3 Tetramisole (6-phenyl-2,3,5,6-tetrahydroimidazoĳ2,1-b]ĳ1,3]thiazole) Not determined; DSC, PXRD 38
1 : 3 3-Hydroxy-4-(2,4,5-trifluorophenyl)butanoic acid Not determined; DSC, PXRD, HPLC 21
1 : 4 Carvone (2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one) Not determined; DSC 39
1 : 5 4-Methyl-7-methylenetricycloĳ7.2.1.01,5]dodecan-12-one oxime Determined 40
1 : 2 Bicyclic bis-lactam derivative BBL7 Determined 41
1 : 2 Exo-trans-exo-(13R,24R)-14,23-dioxaoctacyclo (25.3.0.02,5.03,29.04,8.06,10.09,13.024,28)
triacontane-15,22-dione
Determined 42
1 : 2 1-(Hydroxymethyl)-4,10-dimethyl-3-oxatricycloĳ5.2.1.02,4]decan-10-ol Determined 43
1 : 2 2-Diisopropylcarbamoyl-3-methylpentane-3,4-diol Determined 44
1 : 2 rac-2,2′-diĲEthoxycarbonyl)-6,6′,7,7′-tetramethoxy-1,1′,2,2′,3,3′,4,4′-octahydro-1,1′-
bisisoquinoline
Determined 45
1 : 2 (E)-3,4-Di-t-butyl-1,1,2,2-tetrakisĲtrimethylsilyl)-1,2-disilacyclobutane Determined 46
1 : 2 trans-(1RS,3RS)-2-N,N′-Dimethylaminomethyl-1,3-dithiolane-1,3-dioxide Determined 47
1 : 2 3-Propyl-4-(p-toluenesulfonylamino)-1,2-diselenolane Determined 48
1 : 3 3-(2-tert-Butylphenoxy)-propane-1,2-diol Determined 49
1 : 3 6-(Dimethoxymethylene)-dibenzoĲd,k)tricycloĲ5.2.2.03,7)undeca-4,10-dien-8-one Determined 50
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butyric acid via rapid crystallization from a highly supersatu-
rated aqueous solution containing both enantiomers in the
ratio of about 1 : 2. They found that the homogeneous precip-
itate obtained via such crystallization has a unique optical ac-
tivity value. Its angle of optical rotation [α]D was +/−7.2°,
while the same parameter for the enantiomers was +/−22°.
On this basis, they stated that the compound in question
could crystallize in the racemic form and two additional com-
pounds 1 : 2 and 2 : 1. Quite recently (2015), A. A. Bredikhin
et al.52 proved in a reinvestigation via IR spectra, SCXRD and
PXRD analysis, and solubility data that no additional com-
pounds exist in the system. Taking this into account, we did
not include the system in Table 2.
Naringenin. Furthermore, Table 2 does not include the
system of naringenin enantiomers, which was studied by
P. J. Cox et al.53 The authors synthesized racemic naringenin
via recrystallization of the precursor substance from an eth-
anol solution. They detected the micro-inhomogeneity of a
crystal of racemic composition. Despite the fact that its
crystal structure corresponds to that of the racemate, the
crystal is a combination of two types of unit cells; those of
the 1st type are populated with R- and S-molecules in pro-
portions of 77.5% and 22.5%, while the proportions in the
2nd type unit cells are 22.5% and 77.5%, respectively. These
proportions roughly correspond to compositions of S :R =
3 : 1 and 1 : 3. The authors53 assumed that the matter ana-
lyzed was a solid solution. Later, J. E. Tabora et al.21 men-
tioned that the existence of unit cells with 1 : 3 and 3 : 1
populations in the crystal structure of racemic naringenin
can be indirect evidence of the presence of 1 : 3 phases in
the system. In our opinion, this crystal structure can be
regarded as a partially disordered racemate since the au-
thors21 showed it to be centrosymmetric (present authors'
note: pseudo-centrosymmetric).
As a result, Table 2 contains 16 systems with non-
equimolar discrete compounds of which we have knowledge.
It should be mentioned that crystal structures of four of the
listed compounds have not yet been clarified.21,36–39 For ex-
ample, paper21 reports the results of the crystallization of dif-
ferent mixtures of the 3-hydroxy-4-(2,4,5-trifluorophenyl)
butanoic acid enantiomers from toluene solutions. In the ter-
nary phase diagram, two additional eutonics and a maximum
in-between were detected. The composition S :R = 1 : 3, corre-
sponding to the maximum, showed both a unique melting
point and X-ray powder pattern, leading to the conclusion
that it is a discrete compound.
Thus, the compounds found in the systems discussed
must be further investigated since a final conclusion can be
drawn only after depicting their crystal structures. For this
reason, the detection of such compounds can be considered
completely valid only for 12 (ref. 29, 40–50) of the systems
shown in Table 2. Among them, 1 : 2 and 1 : 3 compounds are
reported for eight and three cases, respectively; for one sys-
tem, a 1 : 5 compound is described. Beside our research on
the malic acid system in section 3.2, two examples shall be
briefly mentioned.
R. G. Kostyanovsky et al.41 determined crystal structures
for two chiral compounds belonging to the group of bicyclic
bis-lactam (BBL). There, compound BBL7 is composed of
three different, independent homochiral chains: two of them
comprising molecules of the same chirality, –R–R–R–, while
the third contains molecules of chirality –S–S–S–. Therefore,
it could be classified as a compound of an S :R = 1 : 2 type.
A. A. Bredikhin et al.49 studied the 3-(2-tert-butylphenoxy)-
propane-1,2-diol system and found an additional peak in the
DSC curve for the composition with an S :R ratio close to
1 : 3. SCXRD analysis of that sample allowed identification
of a discrete phase and its crystal structure.
3.2 The system (S)-malic acid–(R)-malic acid
3.2.1 History. The system of malic acid enantiomers has
been investigated over decades. One of the four carbon atoms
forming the malic acid C4H6O5 molecule includes a chiral
center. As already mentioned, it is a representative of the chi-
ral systems containing a racemic compound,54 and it is also
remarkable for being an example of the combination of a few
complications discussed in the work.6 For example, the RS
compound can crystallize in various polymorphic modifica-
tions. The data on the crystal structure and diffraction spec-
tra of the two monoclinic modifications of RS-malic acid
(designated as RSI and RSII in the following), as well as the
malic acid enantiomers, are available from the Cambridge
Structural Database (CSD)55 and the International Centre for
Diffraction Data (ICDD).56 In the crystal structures of the
S-enantiomer and racemic compounds RSI and RSII, malic
acid molecules form chains with neighbour molecules in the
chains being linked by hydrogen bonds.57–60 This is a com-
mon arrangement for dicarboxylic acids, such as
terephthalic,61 succinic62 and adipic62 acids.
In addition to the racemic compound, the presence of
“anomalous racemates” in the malic acid system was firstly
reported in paper.37 The authors studied some enantiomeric
compositions using HSM and plotted the phase diagram. Be-
sides the maximum corresponding to the racemic compound
(RSI, the only modification known at that time), they found
additional inflexion points of the liquidus line at composi-
tions S :R = 3 : 1 and 3 : 1. They also found that the sample
crystallized from aqueous solution with the composition S :R
= 1 : 3 was characterized by a unique diffraction pattern.
Later, the authors of other work63 discovered a second mono-
clinic polymorph of the racemic compound (RSII). They as-
sumed that the inflexions of the liquidus line discovered by
previous authors resulted from the intersections of two
liquidus lines belonging to the different polymorphs of the
racemic compound, which, consequently, could not be proof
of the anomalous racemates existence. For many years, this
point of view has prevailed. Later, H. Kaemmerer et al.26 car-
ried out experiments to verify that the racemic forms RSI and
RSII are monotropically related. They showed that the lower
melting form RSII undergoes a polymorphic phase transition
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proved monotropy in accordance with the heat-of-fusion
rule.64 DSC and DTA studies on S- and RS-malic acid have
been also reported by other authors.65
3.2.2 Phase relations in the system based on PXRD,
TRPXRD, IR-spectroscopy, DSC and HSM investigations
Phase diversity in the (S)-malic acid–(R)-malic acid system.
The system of malic acid enantiomers appeared to be more
complex than it seemed before. Firstly, along with the known
monoclinic modifications RSI and RSII, a third modification
of the racemic compound RSIII can be formed. Secondly, in
addition to the equimolar compound RS, non-equimolar dis-
crete phases with the ratio S :R = 3 : 1 and 1 : 3 occur that
thirdly, can crystallize as stable S3R (SR3) and metastable
3S1R (1S3R) modifications. Moreover, the discovery of addi-
tional discrete phases necessitated further adjusting the
limits of solid solutions in this system.
Equimolar discrete compounds. PXRD studies of samples
of the racemic compounds crystallized from various solvents
showed27 that the polymorphic diversity of the RS compound
depends, first of all, upon the crystallization medium and the
crystallization rate (ESI:† Table 1). The influence of some
other crystallization conditions is discussed in details in the
paper.27 Phase distribution of the crystallization products
according to the crystallization time (ESI:† Table 1) correlates
with estimation of the stability of the various phases based
on DSC data.
Non-equimolar discrete compounds. A PXRD study of
samples with an enantiomer ratio of S :R = 3 : 1 (1 : 3) allowed
the determination of stable S3R (SR3) and metastable
modifications 3S1R (1S3R) of 3 : 1 and 1 : 3 discrete
compounds in the system.66 As for the racemic compound,
the diversity of the polymorphic modifications of these
compounds depends upon the crystallization medium and
the crystallization rate (ESI:† Table 1). The presence of the
non-equimolar discrete phases in the system was also con-
firmed by IR-spectroscopy, DSC and HSM studies. We
obtained IR spectra of the malic acid equimolar and non-
equimolar compounds in the area of 4000–400 cm−1.
Fig. 2a and b show the IR spectra of S-enantiomer, racemic
compounds RSI and RSII and non-equimolar S3R and 3S1R
discrete phases in the diagnostic ranges of 3600–3300 cm−1
and 1740–1630 cm−1. It can be seen that each of the phases
S, RSI, RSII, SR3, and 3S1R, of malic acid has its own spec-
trum that allows for the use of IR-spectroscopy for their iden-
tification. The results for the known racemic and enantiomer
phases agree with data reported in the works26,63 and do not
contradict other literature findings.67
Phase relationships in the (S)-malic acid–(R)-malic acid
system. The TRPXRD method showed that the racemic phases
RSI and RSIII do not undergo polymorph transformations
until the substances reached their melting points at 124 °C
and 123 °C, respectively. However, heating a sample of an
RSI + RSIII mixture resulted in a homogenization at 110–123
°C to form RSI and the subsequent melting of the latter at
124 °C. In addition, a slurry experiment where a RSI + RSIII
mixture was slurried in an acetonitrile solution for 1 month
also showed RSI to be stable and RSIII to be metastable.
Upon heating, the RSII phase transforms into RSI at a
temperature of 106–108 °C. The experiments confirmed
stability of the RSI phase, the obvious metastability of RSII,
and the less obvious metastability of RSIII at ambient
temperature.
Fig. 3 shows the DSC melting curves for the three racemic
phases and the non-equimolar S :R = 3 : 1 modifications of
malic acid. The melting temperatures increased in the order
3S1R, S3R, RSII, RSIII, RSI. Based on the heat-of-fusion rule,
64
the monotropic relationships between the polymorphs RSI,
Fig. 2 IR spectra in the ranges 3600–3300 cm−1 (a) and 1800–1500
cm−1 (b) of S-enantiomer (red line), racemic compounds RSI and RSII
(black and green lines), stable S3R and metastable 3S1R compounds
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RSII and RSIII of the racemic compound as well as the poly-
morphs S3R and 3S1R of the non-equimolar discrete com-
pounds could be proven (Fig. 3).
Thermomicroscopic (HSM) investigations of the
S-enantiomer, racemic compounds RSI and RSII, physical
mixtures of enantiomers S + R with the proportions of 1 : 1
and 1 : 3 for the components, and the non-equimolar discrete
compounds S3R and 3S1R were performed (ESI:† Fig. 1).
Close to the DSC results, the heating of the enantiomer and
racemates RSI and RSII did not lead to any noticeable
changes until melting of the substances. Instead of powders,
in experiments with a 1 : 1 physical mixture of enantiomers S
+ R, we used two homochiral crystallites obtained by
quenching the melt of the corresponding enantiomers (ESI:†
Fig. 1a). The interaction between the enantiomers starts at
the contact area of the two grains and leads to the formation
of racemic compound. This correlates with the fact that the
crystallization of a melt containing two enantiomers provides
the compound RSII (ESI:† Table 1). Experiments with the 3 : 1
physical mixture (S + R) were run with powders (ESI:†
Fig. 1b). They resulted in the formation of the discrete com-
pound that finally melts. After recrystallization, a crystallite
was taken, which was the metastable discrete phase 3S1R,
and analyzed (ESI:† Fig. 1c). A visible transformation of the
metastable into the stable phase, 3S1R → S3R, was not ob-
served. The substance melted and recrystallized after removal
of the heat.
The thorough study of the malic acid system resulting in
identification of various modifications of the equimolar and
non-equimolar discrete phases as well as the limits of solid so-
lutions in two of the systems28 facilitates compiling a schematic
representation of the phase diagram (Fig. 4). It is based on the
data obtained by the PXRD, TRPXRD, DSC, HSM, IR, and
SCXRD methods mentioned. The given melting points originate
from both the DSC and TRPXRD results. The limits of solid so-
lutions were allocated using the results of a PXRD study of mol-
ten mixtures (ESI:† Fig. 2). When compared with the known di-
agrams of the second type5,21 (see Fig. 1), the diagram of the
malic acid system is very complex with the following character-
istics. 1) The racemic compound can form three polymorphic
modifications, with two of them already known26,58–60,63,65 (RSI
and RSII), and the third one (RSIII) discovered by the present
authors.27 2) Non-equimolar discrete compounds with the ratio
S :R = 3 : 1 and 1 : 3 (ref. 29) are formed in the system. 3) The
non-equimolar discrete compounds can crystallize in stable
(S3R and SR3) and metastable (3S1R and 1S3R) modifications.
4) Studies of the detected discrete phases allow determination
of the areas of solid solutions in this system, which are found
in the vicinity of all the discrete phases.28
Fig. 3 DSC curves and derived melting data of the racemic
compounds RSI, RSII, and RSIII and the S3R and 3S1R compounds of
malic acid.
Fig. 4 Schematic representation of the phase diagram of the malic acid enantiomers (not scaled) with melting temperatures added. Explanations
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3.2.3 Crystal structure of compound S3R. Definitive confir-
mation of the existence of non-equimolar discrete com-
pounds in the system became possible after determining the
crystal structure of the stable compound S3R. A single crystal
with the S :R ratio of 75 : 25% obtained from an acetonitrile
solution via an isothermal evaporation method was studied
by means of SCXRD. The crystal structure data and structure
refinement of the compound are presented in ESI:† Table 2.
The powder X-ray diffraction pattern calculated using the
structural data (ESI:† Fig. 3a) is consistent with the experi-
mental diffractogram of the stable compound S3R (ESI:†
Fig. 3b) and differs from the pattern of the metastable com-
pound 3S1R (ESI:† Fig. 3c). ESI:† Table 3 shows the triclinic
cell parameters of the compound S3R in comparison to the
other discrete phases in the system.
Fig. 5 presents the crystal structure of the compound S3R
in projections on the planes ab (a), bc (b), and ac (c). It might
be described as an arrangement of molecular chains of two
types. Chains of the first “enantiomeric” type are composed
of molecules of the same chirality –S–S–S–S–, while chains of
the second “racemic” type include alternating molecules of
both chiralities –S–R–S–R–.
ESI:† Fig. 4 shows projections of the crystal structures of
racemate RSI, racemate RSII, S-enantiomer, and compound
S3R onto the ab and bc planes. The most interesting for anal-
ysis of these crystal structures are their projections on the ac
plane depicted in Fig. 6. It can be seen that the neighbor
molecules within the chains are interlinked via hydrogen
bonds in all the crystal structures of RSI (Fig. 6a), RSII
(Fig. 6b), S (Fig. 6c), and S3R (Fig. 6d). For a convenient de-
scription, two opposite edges of the molecules will be desig-
nated here as a “head” and a “tail”, where the head is the
end of the molecule, which is closer to the side OH group,
while the opposite end is, correspondingly, the tail.
In the crystal structures of racemate RSI, S-enantiomer and
compound S3R, the neighbor molecules have “head-to-head,
tail-to-tail” connections. Molecules of different chiralities are
characterized by the same conformation in the case of RSI
chains and “racemic” chains of S3R. Alternatively, molecules
of the same chirality in the case of enantiomer chains and
“enantiomeric” chains of S3R are characterized by two confor-
mations; this allows interlinking of such molecules. The crys-
tal structure of RSII contains “head-to-tail” arrangements of
molecules. As for RSI, the molecules are also characterized by
different chiralities and by the same conformation.
In the crystal structures of all the malic acid compounds,
the hydrogen bonds between neighbor molecules are
conducted by the edge COOH groups. Two COOH groups be-
longing to neighbor molecules form carboxylic dimers (dimer
ring). The differences in H-bond topography between various
compounds (RSI, RSII, S, and S3R) are due to the number of
such contacts linking the molecules of the neighbor chains.
In the case of RSI (Fig. 6a), there is an alternating number of
H-bonds that connect the carboxylic rings corresponding to
the neighbor chains. Carboxylic rings forming four contacts
alternate with those forming six contacts. In Fig. 6, the con-
tacts connecting the carboxylic dimers, as well as the contacts
forming the dimers, are shown by the blue dashed lines. In
Fig. 5 Crystal structure of malic acid compound S3R in projections
upon the ab (a), bc (b), and ac (c) planes. On the bc projection (b), the
S- and R-molecules are denoted by blue and red shadows, respectively.
Fig. 6 Crystal structures of the racemic compounds RSI (a) and RSII
(b), enantiomer S (c), and compound S3R (d) of malic acid in
projections upon the ac plane. The color designations of the S- and
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the case of RSII (Fig. 6b), there are no hydrogen bonds be-
tween the neighbor chains. In the case of the S-enantiomer
(Fig. 6c), only half of the carboxylic rings are connected to
those of a neighbor chain. There are five H-bonds per one
ring. Moreover, there are two H-bonds on both sides from
the ring that connect the pendant OH groups of the mole-
cules corresponding to the neighbor chains. The contacts are
shown by green dashed lines. In the case of S3R (Fig. 6d),
there are rings of four types. This is due to molecular chains
of two types alternating in the crystal structure – enantio-
meric and racemic. In the enantiomeric chains, there are al-
ternating dimers with three and two contacts with the neigh-
bor chains. In the racemic chains, there are alternating
dimers forming two and four such contacts.
For convenience, the crystal structures described are sche-
matically shown in Fig. 7(a–d). The use of different colors en-
ables distinguishing S- and R-enantiomer molecules, and the
OH groups are indicated to recognize the “tails” and the
“heads” of the molecules. The molecule shape reflects its con-
formation – a straight shape corresponds to the “racemic”
conformation, while the slanted shape corresponds to the
“enantiomeric” conformation. This representation shows the
principle packing ofmolecular chains of two types in the crystal
structure of the compound S3R. The crystal structure is a com-
bination of the racemate RSI chains and S-enantiomer chains.
4. Systems of enantiomers of different
compounds containing equimolar and
non-equimolar discrete phases
4.1 Systems of enantiomers of different compounds
containing equimolar discrete phases
In the available literature, there are a considerable number of
publications reporting systems composed of enantiomers of
different compounds. Some of these systems belong to the
type two (see Fig. 1) since their equimolar compositions are
discrete compounds. Fifteen examples of such systems are
presented in Table 3,36,68–80 and for ten of the related com-
pounds, the crystal structures were determined using SCXRD.
Almost all the represented enantiomeric molecules have only
one chiral center, the exceptions being (−)-dilactic acid,
(+)-2,4-dimethylglutaric acid and tartaric acid molecules with
two equal chiral centers, i.e., the carbon atoms with the chi-
ral centers have the same substituents.70
The most interesting for our discussion are three systems:
L-malic acid–L-tartaric acid,78 L-malic acid–D-tartaric acid79
and D-valine–L-isoleucine,80 while malic acid and L-valine–L-
isoleucine are, in turn, the subjects of our studies (see
Table 1).
The first two systems differ from each other only in the
type of chirality of tartaric acid as the second component. It
should be noted that malic and tartaric acids have non-
coinciding directions of rotation for the polarized light plane,
which are LĲ−) and DĲ+) for malic acid and LĲ+) and DĲ−) for
tartaric acid. The configuration difference of the tartaric acid
molecule is reflected in the structure of the resulting binary
compounds. The compound formed in the L-malic acid–D-
tartaric acid system has the space group P21, while the one in
the L-malic acid–L-tartaric acid system is characterized by the
space group P1. The schematic representations of the molec-
ular packing in the equimolar compounds of the above sys-
tems and selected discrete phases in the system of malic acid
enantiomers are shown in Fig. 7(e and f) and (a–d), respec-
tively. The third system, D-valine–L-isoleucine, differs from the
one we studied only in having a different chirality in valine.
This discrepancy determines the differences in the molecular
compositions of the discrete compounds formed in the corre-
sponding systems. A comparative analysis of their crystal
structures is given in section 4.2.
L-Malic acid–D-tartaric acid system (Fig. 7e) is denoted
L–D′. In the molecular chains of the LD′ binary compound of
this system, the malic acid molecules only have the “racemic”
conformation. In contrast to the chain arrangements in malic
acid RSI and RSII (Fig. 7a and b), the neighbor chains are
shifted relative to each other by one molecule in the direction
Table 3 Equimolar discrete compounds in binary systems of enantiomers of different organic compounds
Systems Methods of research Crystal structure Ref.
(+)-Chlorosuccinic acid–(−)-bromosuccinic acid Melt phase diagram Not determined 68
(+)-Mercaptosuccinic acid–(−)-methylsuccinic acid Melt phase diagram Not determined 69
(−)-Dilactic acid–(+)-2,4-dimethylglutaric acid Melt phase diagram Not determined 70
(−)-Thiodilactic acid–(+)-2,4-dimethylglutaric acid Melt phase diagram Not determined 70
(+)-2-Methylglutaric acid–(−)-2,4-dimethylglutaric acid Melt phase diagram Not determined 36
(+)-m-Methoxyphenoxypropionic acid–(−)-m-bromophenoxypropionic acid SCXRD Determined 71
(S)-2-(3-Bromophenoxy)propionic acid–(R)-2-(3-methoxyphenoxy)propionic acid SCXRD Determined 72
(R)-2-(2,4-Dichlorophenyl)propanoic acid–(S)-2-(2-chloro-4-nitrophenyl)propanoic acid SCXRD Determined 73
(R)-N-(4-Methylbenzoyl)-R-methylbenzylamine–(S)-N-(4-nitrobenzoyl)-R-methylbenzylamine SCXRD Determined 74
(S)-2-(2,4,5-Trichloroanilino)propanoic acid–(R)-2-(2,4,5-trichlorophenoxy)propanoic acid SCXRD Determined 75




L-Malic–L-tartaric acid SCXRD Determined 78
L-Malic–D-tartaric acid SCXRD Determined 79
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of their elongation. This shift results in the molecules having
a staggered arrangement (Fig. 7e). The tartaric acid molecule
contains two side OH groups, while malic acid only has one.
Hence, the neighbor molecular chains in the crystal structure
of tartaric acid form more hydrogen bonds than the chains
in the crystal structure of the malic acid racemate RSI.
L-Malic acid–L-tartaric acid system (Fig. 7f) is denoted L–L′.
Similar to the LD′ compound, in the molecular chains of the
LL′ discrete compound, the malic acid molecules only have
the “racemic” conformation, and the neighbor chains are
shifted, forming a staggered arrangement. The difference is
that the “heads” of the malic acid molecules in the neighbor
chains of the binary compound LL′ are directed to the same
direction (Fig. 7f), while in the LD′ compound, they face the
opposite sides (Fig. 7e).
4.2 Systems of enantiomers of different compounds
containing non-equimolar discrete phases:
the example of L-Val–L-Ile
We are aware of the existence of only three such systems
containing non-equimolar discrete phases (Table 4). Two of
them have been studied by means of melting point measure-
ments,36,70 and both are cited in Table 3 since they also in-
clude equimolar compounds. According to work,5 these sys-
tems tend to form non-equimolar discrete compounds
because they involve 2,4-dimethylglutaric acid as a compo-
nent. The crystal structures of the 1 : 3 discrete compounds
have not been determined; their presence was indicated by
additional inflexion points in the liquidus lines. Molecules
constituting both systems have different chiralities. Each of
the molecular components of the system (−)-dilactic acid–(+)-
2,4-dimethylglutaric acid has two equal chiral centers, while
the molecules of the system (+)-2-methylglutaric acid–(−)-2,4-
dimethylglutaric acid possess (with one and two) different
numbers of chiral centers.
The principal feature distinguishing the L-valine–L-
isoleucine system from those discussed above is the same –
the L-chirality (configuration) of its components. The valine
molecule has one chiral center; isoleucine contains two un-
equal chiral centers that differ from the (−)-dilactic and
(+)-2,4-dimethylglutaric acid molecules, which have equal chi-
ral centers (Table 4).
At least since 1933,81 studies of solubility of Ile and Val in
combination, and of individual solubilities of Val82,83 and
Ile84,85 have been performed. The equilibria between the
solid and liquid phases in the ternary system L-Val–L-Ile–water
were studied by I. Kurosawa et al.86 (HPLC and PXRD) and by
D. Binev et al.87 (HPLC). H. Koolman and R. Rousseau88 in-
vestigated (SCXRD) the effect of small amounts of Val admix-
ture on the growth and morphology of Ile crystals. The de-
tailed correlation to our findings is discussed in work,34
where most of our results for the L-Val–L-Ile system using
HPLC (11 samples), PXRD (13 compositions), and SCXRD
methods are published. First data obtained by TRPXRD was
recently reported.35
According to the PXRD data, the limits of solid solutions
in the system L-Val–L-Ile are rather limited. The system has
been found to contain a non-equimolar discrete compound
V2I with the ratio Val : Ile = 2 : 1 (∼66 mol% Val). According to
this, three areas of solid solutions (ss) originating from valine
ssV (>70 mol% Val), isoleucine ssI (<10 mol% Val), and dis-
crete compound ssV2I (60–68 mol% Val) were distinguished;
also, two-phase regions were identified consisting of solid so-
lutions ssI + ssV2I (10–60 mol% Val) and ssV2I + ssV (68–70
mol% Val). The results agree well with that obtained by inde-
pendent HPLC studies. As shown in Fig. 8, the ternary phase
diagram of the system L-Val–L-Ile–water contains a local solu-
bility minimum that corresponds to the composition of ∼66
Fig. 7 Schematic representations of molecular packing in the crystal
structures of racemic compounds RSI (a) and RSII (b), non-equimolar
compound S3R (c), and S-enantiomer (d) in the system formed by
enantiomers of the same compound, i.e., (S)-malic acid–(R)-malic acid,
and in the crystal structures of equimolar compounds LD′ (e) and LL′ (f),
in the systems formed by enantiomers of different substances, i.e.,
L-malic acid–D-tartaric acid and L-malic acid–L-tartaric acid, corre-
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mol% Val and is positioned in-between two eutonics laying
asymmetrically left and right from it. Such behavior of the
solubility curve is characteristic for systems containing a bi-
nary discrete compound.22,89 Although the absolute solubility
data (obtained by different methods) differ slightly from each
other, they clearly indicate the local solubility minimum close
to the 2 : 1 Val : Ile composition and verify the presence of the
related V2I compound in the system.
Crystal structure of compound V2I. Crystal structures of
the system components, valine and isoleucine, are
known.90–94 The newly discovered non-equimolar discrete
compound V2I has been studied by means of SCXRD.
The monoclinic cells of Val and Ile (space group P21)
(Fig. 9a and b) are characterized by two crystallographically
independent positions of the molecules.90–94 Molecules occu-
pying both positions have the same conformation. The
monoclinic cell of V2I (space group C2) (Fig. 9c) is character-
ized by four independent positions of the molecules, each of
which have mixed populations, i.e., can be occupied by either
a Val or Ile molecule. The parameter a of the V2I monoclinic
cell is doubled in comparison to the corresponding parame-
ters c of Val and Ile monoclinic cells (due to different unit
cell orientations). The empirical formula of compound V2I
calculated on the basis of structural data corresponds to
the Val : Ile ratio of ∼60 : 40 and is practically confirmed
by the composition of the sample studied (66 mol%
Val). The calculated powder X-ray diffraction pattern
shows good agreement with the experimentally obtained
one.34
Similar to the crystal structures of Val90,92,94 and Ile,91,93,94
the crystal structure of the discrete compound V2I is layered.
Molecules in the three crystal structures are combined in
H-bonded dimer molecules, and dimers form molecular
layers also via H-bonds. The layers interact with each other
by van der Waals forces. The Val and Ile dimers are elongated
along the c axis, and the layers are connected by axes 21.
However, the dimers in the crystal structure of V2I are elon-
gated along the a axis, and the layers are connected by axes
21 and 2. The difference in the azimuthal arrangement of the
molecular layers can be seen easily if the doubled unit cell of
Ile and the unit cell of V2I are compared (see ESI:† Fig. 5 and
work34).
Components of the system D-Val–L-Ile are known in the lit-
erature80 and were mentioned before (Table 3). They differ
from those of the system L-Val–L-Ile only by the configuration
of the valine molecules. These systems exemplify the effect of
the different chiralities of the molecules forming a binary sys-
tem. In the first system,80 an equimolar discrete compound
VI (Val : Ile = 1 : 1) is formed, while in the second system, a
non-equimolar discrete compound V2I (Val : Ile = 2 : 1) is
formed. The crystal structures of both compounds are charac-
terized by alternating azimuthally non-equivalent molecular
Table 4 Non-equimolar discrete compounds in binary systems of enantiomers of different organic compounds
Systems Ratio Methods of research Crystal structure Ref.
(+)-2,4-Dimethylglutaric acid–(−)-dilactic acid 3 : 1 Melt phase diagram Not determined 70
(−)-2,4-Dimethylglutaric acid–(+)-2-methylglutaric acid 3 : 1 Melt phase diagram Not determined 36
L-Valine–L-isoleucine 2 : 1 SCXRD, PXRD, TRPXRD Determined 34, 35
Fig. 8 Ternary phase diagram (50 °C) of the system L-Val–L-Ile–water.
Green and blue triangles denote solubility data obtained by
evaporation and cooling methods, respectively. Note that the
solubilities occupy only the upper 1.5 mol% of the diagram. Green
squares denote the compositions of the corresponding solids obtained
from HPLC compositional analyses. Isotherm line is just to guide the
eye (part of the data was published in former work34).
Fig. 9 Projections of the monoclinic cells of Val (a), Ile (b) and the
discrete compound V2I (c) on the ac plane
34 as well as levorotatory
molecules of Val (d) and Ile (e). Atoms C, O, N, and H are colored in
black, red, blue, and gray, respectively. The H atom of Val and CH3
group of Ile are circled. The projections of the monoclinic cells of Val
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layers and by doubled unit cells including two layers in corre-
sponding translation. Wherein, the compound VI crystallizes
in the space group P21, and the compound V2I in the space
group C2.
Schematic representations of the molecular packing in
the crystal structures of Val, Ile, V2I, and VI are shown in
Fig. 10 for comparison. Molecules with L-configuration and
the coordinates y and y + 1/2 at the b axis of the unit cell
are shown in blue and light blue colors, respectively; mole-
cules with D-configuration are in green. Different shapes of
the Val and Ile molecules reflect the fact that in comparison
to Val, the edge H atom is replaced by a CH3 group
in Ile. The group is shown by an additional rear circle.
Partial coloring of the circle in the case of V2I symbolizes
the partial (33%) occupation of the site by a rear CH3
group.
5. Systematization of discrete
compounds formed in binary chiral
systems of organic substances
The term “racemate” or “racemic modification” was intro-
duced as early as the 2nd half of the 19th century after L.
Pasteur's well-known experiments to describe an enantiomer
mixture containing equimolar amounts of the components.
However, this definition does not reveal the nature of the
mixture itself. In the published literature, there are plenty of
terms used for discrete phases in related systems, e.g., true ra-
cemates, false conglomerates, quasiracemates, anomalous ra-
cemates, anomalous quasiracemates, anomalous conglomer-
ates, cocrystals, 1 : 1 complexes, and others. The importance
of knowledge about the variety of solid phases in chiral sys-
tems (e.g., for pharmaceutical and food industries) as well as
the great scope of acquired data made the following ques-
tions emerge: Which particular type of compound is implied
when one of the above definitions is used? How do they re-
late to each other?
We have attempted to systematize the data on discrete
compounds in such systems, and the results are compiled in
Table 5. The systematization is not aimed at changing the
terminology but clarifying what is exactly meant under the
terms mentioned. To make the systematics viable, it is neces-
sary to define the border lines covering the types of com-
pounds that can be included.
First, it is applicable only to chiral compounds that are
“true” organic substances (known to contain a selected num-
ber of chemical elements95) and, therefore, excludes organo-
metallic compounds. Second, the systematization is proposed
only for compounds formed in true binary systems, i.e., sub-
stances composed of only two molecular species. That is why
it does not encompass compounds containing solvent mole-
cules. For example, E. Wachter et al.96 recently described the
crystal structure of a PF6
− salt of [RuĲ2,9-dimethyl-1,10-
phenanthroline)2Ĳdipyridoĳ3,2-d:2′,3′-f ]quinoxaline)]
2+ with the
enantiomer ratio of 5 : 4. However, the crystal structure of this
compound incorporates molecules of the solvents (acetone,
diethyl ether, and water) in addition to the organometallic
component. Third, we only consider hydrogen and van der
Waals-bonded crystals where the molecular components are
related to each other as enantiomers or quasi-enantiomers
(including diastereomers).97 Furthermore, attention should
be paid to the term “cocrystals,” which is frequently used in
relation to pharmaceuticals with the potential to improve
their physicochemical properties.98 A broadly accepted defini-
tion of the term comprises substances composed of two or
more neutral molecular components at definite stoichiomet-
ric amounts, which are characterized by structural homoge-
neity and the absence of solvate molecules in their crystal
structure.99,100 Therefore, related compounds include binary
donor–acceptor complexes and crystals with hydrogen
bonds.99 Consequently, the term cocrystal has a rather broad
definition, especially considering chiral and achiral com-
pounds. Accordingly, only cocrystals containing chiral com-
ponents and only two of them find proper positions in our
systematization.
Fig. 10 Schematic representations of molecular packing in crystal
structures of Val, Ile, and non-equimolar compound V2I in the L-Val–L-
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The systematization in Table 5 is based on the following
two principles. Principle 1: Classification according to the
composition of the compound: 1) division into two major
groups, viz.: equimolar and non-equimolar discrete com-
pounds (at top and bottom of Table 5), and 2) further divi-
sion into two subgroups, viz.: homomolecular and hetero-
molecular compounds, i.e., compounds composed of
molecules of the same or different substances. Principle 2:
Classification within each one of the four resulting sub-
groups according to 1) compound stereochemistry (enantio-
mers or diastereomers) and 2) crystallographic features. Each
subsection in the table provides particular examples. The ref-
erences given there correspond to the original publications
with the authors' definitions.
Homomolecular (racemic) compounds
Homomolecular (racemic) compounds can be divided into
centrosymmetric and non-centrosymmetric compounds.
Centrosymmetric compounds of this group are repre-
sented only by racemic compounds or true racemates.5 They
form the most abundant and most frequently studied group.
In the compounds, molecules form dimers, wherein a dextro-
rotatory molecule is connected to a levorotatory one via an in-
version center. One of the feasible examples is racemic malic
acid of the RSI modification.27–29
Non-centrosymmetric compounds of this group are much
less frequently occurring and can be divided into three sub-
groups. The first one is also represented by racemic com-
pounds. S and R molecules do not form dimers here; they are
combined via other symmetry elements instead of an inver-
sion center. It includes the RSII modification of racemic ma-
lic acid discussed before.27–29 The second subgroup consists
of kryptoracemates,101 also known as false conglomerates.102
In compounds of this type, S and R molecules occupy inde-
pendent crystallographic positions, i.e., they are not
connected via symmetry elements. According to the au-
thors,101 about 180 substances form compounds of this type.
The third subgroup is comprised of compounds named 1 : 1
complexes,104 where the components are diastereomers of the
same substance and can have either the same chirality (S : Sa
and R :Ra) or different chiralities (S :Ra and R : Sa). Diastereo-
meric molecules forming such pairs cannot be related via
symmetry elements.
Heteromolecular compounds 1 : 1
Heteromolecular compounds 1 : 1 cannot be centrosymmetric
by definition. However, they can also be classified into two
subgroups: pseudo-centrosymmetric and non-
centrosymmetric ones.
Pseudo-centrosymmetric compounds of this type are
known to be reported as quasiracemates.105 They contain
enantiomer molecules of different substances (see Table 3).
However, structural differences between the molecules are
rather insignificant, and, usually, they differ only by one
atom or a small group of atoms. In some works,97 the term
“quasienantiomers” is used for such molecules. In a crystal
structure, a pair of such molecules usually forms a dimer,
wherein the molecules are connected to each other via a
pseudo-inversion center.
Non-centrosymmetric compounds of this group can be
subdivided into two subgroups. One of them would include
cocrystals,79 i.e., the system components are enantiomers of
different substances. The other one contains 1 : 1 com-
plexes,97,106 wherein the system components are diastereo-
mers of different compounds.
Homomolecular compounds 1 : N
Homomolecular compounds 1 : N (Table 5, bottom part) can
formally be classified into two subgroups. One of them con-
tains anomalous racemates51 or anomalous conglomerates.52,107
Both terms were introduced to define non-equimolar com-
pounds formed by enantiomers. Compounds of this type
have not been found yet among diastereomeric pairs. Systems
containing anomalous racemates are rather rare and scarcely
studied, and most publications, with a couple of minor ex-
ceptions, are devoted to compounds of enantiomer pairs with
the enantiomer ratio of 1 : 3 (see Table 2). Examples include
the stable S3R and metastable 3S1R modifications of malic
acid described above.
Heteromolecular compounds 1 :N
Heteromolecular compounds 1 : N (Table 5, bottom part)
form the rarest group, and the number of reported studies
of such compounds is very limited. Technically, three sub-
groups can be distinguished. The first one was named
anomalous quasiracemates50 and contains compounds of
enantiomer molecules of different substances. The term
has been introduced to denote 1 :N compounds formed in
addition to quasiracemates in systems of components of
different chiralities. The second subgroup (no name yet) in-
cludes compounds occurring in systems of components
of the same chirality; such systems do not produce
quasiracemates. A representative of this subgroup, com-
pound V2I, has been depicted above. The third subgroup
(also no name yet) is comprised of compounds formed
by diastereomers of different substances. We know only
three systems forming 1 :N heteromolecular compounds
(see Table 4), and they belong to the first and second
subgroups.
According to statistical data,96 the occurrence of non-
equimolar discrete compounds among substances with chiral
molecules is negligible, being 1 : 100 000. If so, is their study
practical? We think that it is. Their physicochemical proper-
ties (beneficial, harmful, or neutral) have not been suffi-
ciently investigated yet. We suppose that this may change in
the future provided the examinations of chiral systems
(enantiomers and diastereomers) are performed using a com-
bination of precision methods. Both systems that we investi-
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6. Summary
Information on non-equimolar discrete compounds in binary
systems of chiral organic substances, which is available in
the literature, has been reviewed and systematized, including
the rate of occurrence of such systems and the current state
of knowledge in the field.
For the systems (S)-malic acid–(R)-malic acid and L-valine–
L-isoleucine, as examples representing different types of bi-
nary systems, the crystal structures of the non-equimolar dis-
crete compounds were analyzed on the basis of comprehen-
sive experimental studies. The results obtained were
compared with the data reported in the literature for these
two and other similar systems.
The (S)-malic acid–(R)-malic acid system was shown to
form 1) an equimolar compound, which could occur in three
modifications; two of these, the RSI and RSII modifications,
have been known for some time, while the third form, RSIII,
was discovered and described by the present authors, and 2)
the non-equimolar stable (S3R and SR3) and metastable (3S1R
and 1S3R) compounds with ratios S :R equal to 3 : 1 and 1 : 3,
correspondingly. Crystallization conditions resulting in the
formation of a particular modification of both equimolar and
non-equimolar compounds have been ascertained, and the
polymorphic transformations between the discrete phases
have been studied. The data obtained were used to plot a
schematic representation of the system phase diagram. The
(triclinic) crystal structure of the non-equimolar discrete com-
pound S3R has been identified and compared to those of the
S-enantiomer and the racemic compounds RSI and RSII. At
present, information on the crystal structures of non-
equimolar discrete compounds is available only for a dozen
systems of enantiomers of the same compound of which we
have knowledge (including our data).
For the L-valine–L-isoleucine system, the occurrence of a
non-equimolar compound V2I with the Val : Ile ratio of 2 : 1
could be proven. The solubility diagram plotted for the
ternary L-valine–L-isoleucine–water system exhibits two
eutonics located on both sides from the local solubility mini-
mum, which corresponds to the composition of compound
V2I. The (monoclinic) crystal structure of the V2I compound
has been determined and compared to those of the system
components L-Val, L-Ile and the equimolar compound formed
in the D-Val–L-Ile system. To the best of our knowledge, this is
the only available information on the crystal structure of a
non-equimolar compound in a system of enantiomers of dif-
ferent substances and, at the same time, the only example of
a binary compound where these enantiomers are of the same
chirality.
Based on the results of the study, a systematization of dis-
crete compounds occurring in binary chiral systems of or-
ganic substances was proposed. This was motivated by the
great scope of the acquired knowledge and the variety of
terms used in the literature. The presented systematics define
chemical and crystallographic characteristics of the discrete
compounds that can be ascertained when using a particular
term. To increase its applicability, the types of compounds
covered with the systematization were defined. Of course, we
do not consider this systematization as complete and all-
encompassing. New materials are steadily appearing that
might fill the still empty places in the systematization table
and support a deeper understanding of the structure–prop-
erty relationships within the systems studied.
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